The Endocrine Society’s new guidelines advise bisphosphonates and denosumab as first line for lower-risk women and anabolic treatments as first line for those at very high fracture risk.
Medscape Medical News …read more
Miami OBGYN Society
A Membership Organization of South Florida Obstetrician-Gynecologists
